Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Jan 29;3(4):402-404.
doi: 10.1002/mdc3.12317. eCollection 2016 Jul-Aug.

Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations

Affiliations
Case Reports

Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations

Claudio M de Gusmao et al. Mov Disord Clin Pract. .

Abstract

Mutations in the ATP1A3 gene (the α-3 subunit of the Na+/K+ ATPase) are associated with rapid-onset dystonia-parkinsonism; alternating hemiplegia of childhood; and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS syndrome). The authors report 3 cases with pleiotropic movement disorders, including a novel mutation in a patient who presented with ataxia and dysphagia. Case 1 had a history of attention deficit hyperactivity disorder and developed dysphagia, chorea, and limb dystonia after a febrile illness at age 12 years. Case 2 presented with limb dystonia at age 26 years and dysarthia and dysphagia after a febrile illness. Case 3 had a history of learning disability and developed progressive ataxia with cerebellar atrophy at age 20 years. In all cases, deleterious mutations were identified in ATP1A3. They illustrate wide phenotypic variability, including chorea and ataxia. New cases are likely to be diagnosed as knowledge about the phenotypic spectrum expands.

Keywords: ataxia; dystonia; parkinsonism; rapid‐onset dystonia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Magnetic resonance images of the patient described in case 3. (A) In a sagittal, fluid‐attenuated inversion recovery image, vermian atrophy is seen. (B) An axial T2 image reveals thinning of cerebellar folia with prominent cerebrospinal fluid spaces.

References

    1. Heinzen EL, Arzimanoglou A, Brashear A, et al. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol 2014;13:503–514. - PMC - PubMed
    1. Demos MK, van Karnebeek CD, Ross CJ, et al. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome [serial online]. Orphanet J Rare Dis 2014;9:15. - PMC - PubMed
    1. Paciorkowski AR, McDaniel SS, Jansen LA, et al. Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly. Epilepsia 2015;56:422–430. - PMC - PubMed
    1. Brashear A, Ozelius LJ, Sweadner KJ. ATP1A3 mutations: what is the phenotype? Neurology 2014;82:468–469. - PubMed
    1. Cook JF, Hill DF, Snively BM, et al. Cognitive impairment in rapid‐onset dystonia‐parkinsonism. Mov Disord 2014;29:344–350. - PMC - PubMed

Publication types

LinkOut - more resources